Welcome

 

The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft with the aim of combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods linking molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.

If you like to support our research, donations are very welcome. For bank details, please send a short request to office@lbiad.lbg.ac.at.

Thank you very much!

Awarded DOC fellowship

Awarded DOC fellowship

We are very proud to announce that Loan Tran, PhD student of the program line Molecular Pathology, was awarded a...
Read More
MIC Festival 2019

MIC Festival 2019

The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on...
Read More
New Chelator for Radiolabelling

New Chelator for Radiolabelling

In a joint research effort supported by the Swiss National Science Foundation, the groups of Prof. Gilles Gasser (Chimie ParisTech)...
Read More
2nd Scientific Advisory Board Meeting

2nd Scientific Advisory Board Meeting

A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had...
Read More
What about industry?

What about industry?

Thomas Dillinger, PhD student of our LBI’s Program Line Molecular Pathology, has spent two months with Boehringer Ingelheim in Vienna...
Read More
Japan – One Year Later

Japan – One Year Later

By Loan Tran, PhD student, PL Molecular Pathology, Egger group Internship (05.02.18-30.03.18) at Division of Pharmacotherapeutics, Keio University Faculty of...
Read More
Congratulations!

Congratulations!

Congratulations to Dr. med. univ. Johannes Längle to the Researcher of the Month Award! Fitting to this month’s Colorectal Cancer...
Read More
13th OGNMB Congress in January 2019

13th OGNMB Congress in January 2019

The 13th National OGNMB Congress took place from the 23rd to the 25th of January 2019 in Zell am See...
Read More
Markus Zeitlinger received several grants

Markus Zeitlinger received several grants

Congratulations to Markus Zeitlinger, head of the Department of Clinical Pharmacology and key researcher of LBI:AD’s program line Clinical Applications....
Read More
Johannes Längle erhielt den Theodor-Billroth-Preis

Johannes Längle erhielt den Theodor-Billroth-Preis

(Wien, 08-01-2019) Der Theodor-Billroth-Preis der Wiener Ärztekammer ging heuer dreigeteilt mit Johannes Koren und Johannes Längle an zwei Forscher der...
Read More